Amphastar P (AMPH)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		5.61	5.05	5.17	5.15	5.62	6.29	5.90	6.22	5.56	5.29	5.66	4.72	5.30	6.44	6.70	5.66	7.10	7.26	6.64	5.75
DSO	days	65.11	72.23	70.66	70.83	64.96	58.04	61.85	58.68	65.70	69.05	64.53	77.27	68.86	56.68	54.49	64.45	51.38	50.26	54.99	63.43

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.61
= 65.11

To analyze Amphastar Pharmaceuticals Inc's days of sales outstanding (DSO) over the past eight quarters, we observe a fluctuating trend. In Q4 2023, the DSO stood at 65.11 days, a decrease from the previous quarter. This suggests that the company collected its accounts receivable more efficiently and quickly during this period. However, compared to Q4 2022, there was a slight increase in DSO.

Looking back further, there was an increasing trend in DSO from Q1 2022 to Q3 2022, indicating potential challenges in collecting receivables efficiently. However, this trend reversed in Q4 2022 with a notable decline in DSO, suggesting improved collections performance.

Overall, while there have been fluctuations in DSO over the quarters, it is essential for Amphastar Pharmaceuticals Inc to monitor and manage its accounts receivable effectively to maintain healthy cash flows and financial stability.